NIP 531
Latest Information Update: 31 Jan 2008
At a glance
- Originator Nissan Chemical Industries
- Class
- Mechanism of Action Histamine H1 receptor antagonists; Neurokinin 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Atopic dermatitis
Most Recent Events
- 07 Jan 2004 No development reported - Preclinical for Atopic dermatitis in Japan (unspecified route)
- 05 Apr 2001 New profile
- 05 Apr 2001 Preclinical development for Atopic dermatitis in Japan (Unknown route)